Kidney Health-Focused Vera Therapeutics Stock Price Spikes On Heels Of Successful Trial Data

All NewsJune 2, 2025

Vera Therapeutics’ share price surged over 65% during the pre-market trading session after the company released ORIGIN Phase 3 trial data.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent